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The in-hospital mortality (9.5% vs 3.3%, p<0.001) and at 6 months (15.6%
vs 6.6%, p<0.001) were also higher, however, the presence of de novo AF was
not an independent predictor of these events. Most P were discharged in SR
(n=134) and without anticoagulant therapy (n=117). 
95 patients with de novo AF were followed for a median period of
690 days and it was observed the occurrence of ischemic stroke/systemic
embolism in 9 P (9.5%), but only one was under oral anticoagulation. 
AF occurred in 37.5% of P that were in SR on discharge. 
Conclusion The presence of de novo AF was associated with increased
risk of adverse events, although it may constitute only a marker of severity. 
We observed recurrence of AF in a considerable sample, which denotes the
need for appropriate evaluation of thromboembolic risk of these P.
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Background Radiofrequency catheter ablation (RFCA) is increasingly used
in the management of ventricular tachycardia (VT) in arrhythmogenic right
ventricular dysplasia/cardiomyopathy (ARVC/D) but it is associated with a
high level of recurrences.
Objective To determine predictors associated with VT recurrence after
RFCA in ARVC/D.
Methods This study included 85 consecutive patients referred to the Pitié
Salpêtrière Hospital (Paris, France) who underwent a total of 149 RFCA pro-
cedures between 2000 and 2010. Predictors of recurrence of VT following
RFCA were assessed by Cox regression.
Results The mean age of the cohort was 36±13 years, 74 (87.1%) were
men and 80 (95.2%) were proband. 70 (83.3%) experienced spontaneous VT
before diagnosis. 30 (58.8%) patients required ≥2 procedures. In 13 (10.7%)
patients, RFCA was performed through epicardial access. Over a mean
follow- up of 114±60 months, the overall freedom from VT of the 149 proce-
dures was 79%, and 56%, at 1 and 5 years, respectively. The presence of an
epsilon wave and of right ventricular (RV) dysfunction (defined by RV angi-
ography ejection fraction <40% or right area fractional change <35% by TTE)
were associated with higher level of recurrences on multivariate analysis. The
cumulative freedom from VT (Figure) in patients without RV dysfunction nor
epsilon wave was 86% at 1 and 5 years, which was significantly longer than
those without (76% and 47% respectively, P=0.003). 
Conclusion Absence of RV dysfunction or of an epsilon wave are strongly
associated with higher success after VT RFA in ARVC/D. Patients without
those risk factors should therefore be considered as good candidates for VT
ablation.
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Background Atrial arrhythmias (AA) are observed frequently early after
lung transplant and also late after the surgery. Several predictive factors of
post-operative AA after lung transplant have been already identified whereas
those of late AA are still not known. Whether AA after lung transplant
impacts mortality and the optimal strategy of rhythm management are still
debated.
The Purpose of the study was to assess in a large cohort of lung trans-
planted patients the incidence of AA early and late after surgery, their predic-
tive factors and their impact on mortality. 
Methods and results We included 271 consecutive patients single or
double lung-transplanted over a 9-years period in a large French center. We
collected baseline clinical, surgery and post-operative data. The follow-up was
2,9±2,4 years. 33% patients developed post-operative AA. Age (HR=2,35; CI
[1,31-4,24]) and chronic obstructive pulmonary disease (HR=1,028; CI [1,12-
4,03]) were independant predictive factors of post-operative AA. Late AA
occurred 2,2±2,7 years after transplant in 8.8% of the patients. Systolic pul-
monary arterial pressure was the only independent predictive factor of late AA
(HR=1,028; CI [1,001; 1,056]). Double lung transplant was associated with
long term freedom from AF compared with single transplant (p=0,05) whereas
the Kaplan-Meier curve for the development of late atrial flutter was similar
in single and double lung transplant. Early and late AA after surgery showed
no impact on mortality. Bilateral lung transplant was associated with a better
survival.
Conclusion Post-operative AA after lung transplantation are common with
good outcome and contrast with the low occurrence of late organized AA.
Double lung transplantation protects against AF but not AFL. Underlying
electrophysiological mechanisms may explain these observations. Predictive
factors of early and late AA after transplantation are different. Nevertheless
these AA do not impact mortality after lung transplant (figure next page). 
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